Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: A potential pathogenic mechanism

Brain

Volumn 123, Issue 1, 2000, Pages 93-104

  Mirabella, Massimiliano ^a   Di Giovanni, Simone ^a   Silvestri, Gabriella ^a   Tonali, Pietro ^a   Servidei, Serenella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Apoptosis; Mitochondrial encephalomyopathies; mtDNA mutations

Indexed keywords

CYTOCHROME C; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; ENCEPHALOMYOPATHY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; INFANT; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY; PATHOGENESIS; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STRUCTURAL GENE;

EID: 0033981319     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.1.93     Document Type: Article

References (41)

1. Asoh S, Mon T, Hayashi J-I, Ohta S. Expression of the apoptosis-mediator Fas is enhanced by dysfunctional mitochondria. J Biochem (Tokyo) 1996; 120: 600-7.
2. Bhagwati S, Leung B, Shafiq SA, Ghatpande A. Myotonic dystrophy: decreased levels of myotonin protein kinase (Mt-PK) lead to apoptosis in muscle cells. Exp Neurol 1997; 146: 277-81.
3. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17: 37-49.
4. DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease. 2nd ed. Boston: Butterworth-Heinemann; 1997. p. 201-35.
5. Di Mauro S, Schon EA. Mitochondrial DNA and diseases of the nervous system: the spectrum. Neuroscientist 1998; 4: 53-63.
6. Fidzianska A, Goebel HH, Warlo I. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain 1990; 113: 433-45.
7. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. [Review]. Ann Neurol 1995; 38: 705-13.
8. Hetts SW. To die or not to die. An overview of apoptosis and its role in disease. [Review]. JAMA 1998; 279: 300-7.
9. Higuchi M, Aggarwal BB, Yeh ET. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 1997; 99: 1751-8.
10. Higuchi M, Proske RJ, Yeh ET. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 1998; 17: 2515-24.
11. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-6.
12. Krippner A, Matsuno-Yagi A, Gottlieb RA, Babior BM. Loss of function of cytochrome c in Jurkat cells undergoing Fas-mediated apoptosis. J Biol Chem 1996; 271: 21629-36.
13. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. [Review]. Immunol Today 1997; 18: 44-51.
14. Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481-6.
15. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.
16. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996; 184: 1155-1160.
17. Marton A, Mihalik R, Bratincsák A, Adleff V, Petak I, Vegh M, et al. Apoptotic cell death induced by inhibitors of energy conservation - Bcl-2 inhibits apoptosis downstream of a fall of ATP level. Eur J Biochem 1997; 250: 467-75.
18. Mignotte B, Larcher JC, Zheng DQ, Esnaull C, Coulaud D, Feunteun J. SV40 induced cellular immortalization: phenotypic changes associated with the loss of proliferative capacity in a conditionally immortalized cell line. Oncogene 1990; 5: 1529-33.
19. Mirabella M, Engel WK, Passinetti G, Finch CE, Askanas V. Denervation of adult human muscle fibers induces apoptosis, evidenced by fragmentation of nuclear DNA, and increased expression of the clusterin (ApoJ) gene [abstract]. Neurology 1996; 46 (2 Suppl): A270.
20. Mirabella M, Di Giovanni S, Silvestri G, Ricci E, Bertini E, Tonali P, et al. Apoptosis and mitochondrial encephalomyopathies: correlation with phenotype [abstract]. In: Proceedings AACR. Molecular Mechanisms of Apoptosis Regulation; 1998 Jan 9-13. Indian Wells (CA).
21. Mitsui T, Kawai H, Nagasawa M, Kunishige M, Akaike M, Kimura Y, et al. Oxidative damage to skeletal muscle DNA from patients with mitochondrial encephalomyopathies. J Neurol Sci 1996; 139: 111-6.
22. Monici MC, Toscano A, Girlanda P, Aguennouz M, Musumeci O, Vita G. Apoptosis in metabolic myopathies. Neuroreport 1998; 9: 2431-5.
23. Morgan-Hughes JA. Mitochondrial diseases. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. p. 1610-60.
24. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RT, Matsuda H, et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 14681-6.
25. Peter EM, Krammer PH. Mechanisms of CD95 (Apo-1/Fas)-mediated apoptosis. [Review], Current Opin Immunol 1998; 10: 545-51.
26. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: from physiology to diseases. [Review]. Biochim Biophys Acta 1995; 1271: 67-74.
27. Richter C, Schweizer M, Cossarizza A, Franceschi C. Hypothesis. Control of apoptosis by the cellular ATP level. [Review]. FEBS Lett 1996; 378: 107-10.
28. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. [Review]. Cell 1997; 91: 443-6.
29. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. Two COD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675-87.
30. Schon EA. The mitochondrial genome. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The molecular and genetic bases of neurological disease. 2nd ed. Boston: Butterworth-Heinemann; 1997. p. 189-200.
31. Slater AF, Nobel CS, Orrenius S. The role of intracellular oxidants in apoptosis. [Review]. Biochim Biophys Acta 1995; 1271: 59-62.
32. Tews DS, Goebel HH. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exp Neurol 1997; 56: 150-6.
33. Vayssiere JL, Petit PX, Risler Y, Mignotte B. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc Natl Acad Sci USA 1994; 91: 11752-6.
34. Wallace DC. Diseases of the mitochondrial DNA. [Review], Annu Rev Biochem 1992; 61: 1175-212.
35. White E. Life, death, and the pursuit of apoptosis. [Review]. Genes Dev 1996; 10: 1-15.
36. Wolvetang EJ, Johnson KL, Krauer K, Ralph SJ, Linnane AW. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett 1994; 339: 40-4.
37. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
38. Yoneda M, Katsumata K, Hayakawa M, Tanaka M, Ozawa T. Oxygen stress induces an apoptotic cell death associated with fragmentation of mitochondrial genome. Biochem Biophys Res Commun 1995; 209: 723-9.
39. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gòmez-Monterrey I, Castedo M, et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996; 183: 1533-44.
40. Zhivotovsky B, Orrenius S, Brustugun OT, Doskeland SO. Injected cytochrome c induces apoptosis [letter]. Nature 1998; 391: 449-50.
41. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-13.